11 Stocks Moving In Thursday's After-Hours Session
Article Tools
Set News AlertCompanies Mentioned
Symbol | Last | Change |
---|---|---|
ACOR | $6.78 | 0.00% |
AVGO | $443.59 | 0.00% |
CLGX | $81.79 | 0.00% |
CSGP | $758.46 | 0.00% |
EVFM | $3.27 | 0.00% |
11 Stocks Moving In Thursday's After-Hours Session
3/4/21 5:44 PM ET (Benzinga)Print
Gainers
- Ocular Therapeutics (NASDAQ: OCUL) shares are trading higher after the company announced the supplemental New Drug Application for DEXTENZA 0.4 mg for intracanalicular use has been accepted for review by the FDA.
- CoStar Group (NASDAQ: CSGP) shares are trading higher after the company announced it withdrew its bid to acquire CoreLogic.
- Fulgent Genetics (NASDAQ: FLGT) shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued FY21 EPS guidance above estimates.
- Waitr Holdings (NASDAQ: WTRH) share are trading higher after the company announced it agreed to pursue a partnership with Flow Payments to create a compliant marketplace, delivery and payment solution for dispensaries selling cannabis.
- Senseonics (NYSE: SENS) shares are trading higher after the company reported better-than-expected Q4 sales results.
Losers
- CoreLogic (NYSE: CLGX) shares are trading lower after CoStar Group announced it withdrew its bid to acquire the company.
- Gap (NYSE: GPS) shares are trading lower after the company reported worse-than-expected Q4 sales results.
- Broadcom (NASDAQ: AVGO) shares are trading lower after the company reported Q1 earnings results.
- Medallia (NYSE: MDLA) shares are trading lower after the company announced inline Q4 EPS results and issued Q1 2021 revenue guidance below estimates. The company also announced it plans to acquire Decibel.
- Evofem Biosciences (NASDAQ: EVFM) shares are trading lower after the company reported worse-than-expected Q4 EPS results.
- Acorda Therapeutics (NASDAQ: ACOR) shares are trading lower after the company reported worse-than-expected Q4 EPS results.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
No comments:
Post a Comment